Abstract
Fibroblast growth factor receptor 1 (FGFR1) is a plasma membrane protein that transmits signals from the extracellular environment, regulating cell homeostasis and function. Dysregulation of FGFR1 leads to the development of human cancers and noncancerous diseases. Numerous tumors overproduce FGFR1, making this receptor a perspective target for cancer therapies. Antibody-drug conjugates (ADCs) are highly potent and selective anticancer agents. ADCs are composed of antibodies (targeting factors) fused to highly cytotoxic drugs (warheads). The efficiency of ADC strategy largely depends on the internalization of cytotoxic conjugate into cancer cells. Here, we have studied an interplay between affinity of anti-FGFR1 antibodies and efficiency of their cellular uptake. We have developed a unique set of engineered anti-FGFR1 antibodies that bind the same epitope in the extracellular part of FGFR1, but with different affinities. We have demonstrated that these antibodies are effectively taken up by cancer cells in the FGFR1-dependent manner. Interestingly, we have found that efficiency, defined as rate and level of antibody internalization, largely depends on the affinity of engineered antibodies towards FGFR1, as high affinity antibod...Continue Reading
References
Oct 8, 2004·Protein Engineering, Design & Selection : PEDS·Malgorzata ZakrzewskaJacek Otlewski
Aug 11, 2005·Journal of Cell Science·Ellen Margrethe HaugstenJørgen Wesche
Apr 15, 2008·Cancer Immunology, Immunotherapy : CII·Michael M SchmidtK Dane Wittrup
May 16, 2008·Molecular Biology of the Cell·Ellen Margrethe HaugstenJørgen Wesche
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carmen BehrensReuben Lotan
Mar 17, 2011·Cancer Research·Stephen I RudnickGregory P Adams
Jun 30, 2011·The Biochemical Journal·Jørgen WescheEllen Margrethe Haugsten
Apr 15, 2014·Protein Expression and Purification·Aleksandra Sokolowska-WedzinaJacek Otlewski
May 2, 2014·Clinical Science·Stacey J ColemanRichard P Grose
Dec 4, 2014·Trends in Cell Biology·Edward P CarterRichard P Grose
May 20, 2015·Biotechnology Advances·Alicja M SochajJacek Otlewski
Sep 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Teresa HelstenRazelle Kurzrock
Jan 16, 2016·Journal of Nanobiotechnology·Michael Bogdan MargineanuTimothy Ravasi
Apr 16, 2016·Molecular Pharmaceutics·Dylan M GlattRussell J Mumper
May 10, 2017·Molecular Cancer Research : MCR·Aleksandra Sokolowska-WedzinaJacek Otlewski
Aug 5, 2017·Scientific Reports·Łukasz OpalińskiJacek Otlewski
Jan 11, 2018·Journal of Cellular Physiology·Hadi NasiriJafar Majidi
Jan 31, 2018·Frontiers in Immunology·Juan C AlmagroManuel L Penichet
Feb 8, 2018·Journal of Experimental & Clinical Cancer Research : CR·Cécile Chalouni, Sophia Doll
Feb 9, 2018·PloS One·Aleksandra BorekJacek Otlewski
Citations
Jun 9, 2020·Molecular Oncology·Marta PozniakLukasz Opalinski
Dec 24, 2018·Journal of Clinical Medicine·Natalia PorębskaŁukasz Opaliński
Jul 8, 2020·Biomolecules·Eunhee G KimKristine M Kim
Jun 3, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Calvin D LewisVaishali Kapoor
Jul 28, 2020·Photodiagnosis and Photodynamic Therapy·Kohei Nakajima, Mikako Ogawa
Aug 14, 2021·Biochemical and Biophysical Research Communications·Seong-Wook ParkYong-Sung Kim
Aug 28, 2021·Biomolecules·Marta PoźniakŁukasz Opaliński
Oct 13, 2021·Journal of Biomedical Science·Marta PoźniakŁukasz Opaliński
Dec 3, 2021·Biomacromolecules·Natalia PorębskaŁukasz Opaliński